- Home
- SN vs BMRN Comparison
SN vs BMRN Comparison
Compare SN & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SN
- BMRN
- Stock Information
- Founded
- SN 1993
- BMRN 1996
- Country
- SN United States
- BMRN United States
- Employees
- SN N/A
- BMRN N/A
- Industry
- SN
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SN
- BMRN Health Care
- Exchange
- SN Nasdaq
- BMRN Nasdaq
- Market Cap
- SN 13.0B
- BMRN 12.1B
- IPO Year
- SN N/A
- BMRN 1999
- Fundamental
- Price
- SN $107.30
- BMRN $57.50
- Analyst Decision
- SN Strong Buy
- BMRN Buy
- Analyst Count
- SN 8
- BMRN 22
- Target Price
- SN $121.50
- BMRN $93.43
- AVG Volume (30 Days)
- SN 2.0M
- BMRN 2.2M
- Earning Date
- SN 08-07-2025
- BMRN 08-04-2025
- Dividend Yield
- SN N/A
- BMRN N/A
- EPS Growth
- SN 133.24
- BMRN 152.82
- EPS
- SN 3.16
- BMRN 2.71
- Revenue
- SN $5,685,049,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- SN $16.68
- BMRN $12.23
- Revenue Next Year
- SN $11.56
- BMRN $9.99
- P/E Ratio
- SN $33.93
- BMRN $21.25
- Revenue Growth
- SN 27.34
- BMRN 19.36
- 52 Week Low
- SN $60.50
- BMRN $52.93
- 52 Week High
- SN $123.00
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- SN 72.72
- BMRN 55.64
- Support Level
- SN $98.06
- BMRN $53.76
- Resistance Level
- SN $95.53
- BMRN $56.25
- Average True Range (ATR)
- SN 3.82
- BMRN 1.33
- MACD
- SN 1.78
- BMRN 0.42
- Stochastic Oscillator
- SN 94.41
- BMRN 86.90
About SN SharkNinja Inc.
SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.